 I was somewhat uncertain about my HOLD stance in my last article, given on how much of a tear Chemours was. However, the past 2 months have vindicated the stance. Chemours is down more than 2X the SP 500 in the same timeframe. While this is short, it shows us that the market believed the company mispriced. 